JPY 2237.5
(-0.18%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 12.65 Billion JPY | -7.72% |
2022 | 13.31 Billion JPY | 17.62% |
2021 | 12.18 Billion JPY | -5.54% |
2020 | 10.65 Billion JPY | 21.67% |
2019 | 9.75 Billion JPY | 11.77% |
2018 | 8.73 Billion JPY | 13.39% |
2017 | 7.75 Billion JPY | 5.21% |
2016 | 7.21 Billion JPY | 4.27% |
2015 | 7.03 Billion JPY | -3.03% |
2014 | 7.28 Billion JPY | 3.62% |
2013 | 7.01 Billion JPY | 9.52% |
2012 | 6.42 Billion JPY | 3.98% |
2011 | 6.19 Billion JPY | -24.11% |
2010 | 5.59 Billion JPY | 5.16% |
2009 | 5.82 Billion JPY | 1.19% |
2008 | 5.47 Billion JPY | -11.65% |
2007 | 6.04 Billion JPY | 3.43% |
2006 | 5.73 Billion JPY | 10.0% |
2005 | 5.33 Billion JPY | 5.11% |
2004 | 5.08 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 156.51 Million JPY | -95.44% |
2024 Q2 | 3.15 Billion JPY | 1907.83% |
2023 Q2 | 2.6 Billion JPY | 1.93% |
2023 Q1 | 2.56 Billion JPY | -20.55% |
2023 FY | - JPY | -7.72% |
2023 Q3 | 3.02 Billion JPY | 16.04% |
2023 Q4 | 3.4 Billion JPY | 12.33% |
2022 Q1 | 2.51 Billion JPY | -19.5% |
2022 Q3 | 3.11 Billion JPY | 10.87% |
2022 FY | - JPY | 17.62% |
2022 Q4 | 3.22 Billion JPY | 3.36% |
2022 Q2 | 2.81 Billion JPY | 11.62% |
2021 Q4 | 3.12 Billion JPY | 29.66% |
2021 FY | - JPY | -5.54% |
2021 Q1 | 2.35 Billion JPY | -31.84% |
2021 Q2 | 1.75 Billion JPY | -25.52% |
2021 Q3 | 2.41 Billion JPY | 37.64% |
2020 Q4 | 3.45 Billion JPY | 89.02% |
2020 Q2 | 1.95 Billion JPY | 10.41% |
2020 Q1 | 1.76 Billion JPY | -37.83% |
2020 Q3 | 1.82 Billion JPY | -6.41% |
2020 FY | - JPY | 21.67% |
2019 FY | - JPY | 11.77% |
2019 Q1 | 1.83 Billion JPY | -18.0% |
2019 Q4 | 2.84 Billion JPY | 42.16% |
2019 Q3 | 2 Billion JPY | -7.23% |
2019 Q2 | 2.15 Billion JPY | 17.34% |
2018 Q2 | 1.74 Billion JPY | -6.63% |
2018 FY | - JPY | 13.39% |
2018 Q4 | 2.24 Billion JPY | 13.35% |
2018 Q3 | 1.97 Billion JPY | 13.1% |
2018 Q1 | 1.87 Billion JPY | -13.73% |
2017 Q4 | 2.17 Billion JPY | 32.12% |
2017 Q3 | 1.64 Billion JPY | 10.39% |
2017 FY | - JPY | 5.21% |
2017 Q2 | 1.48 Billion JPY | -5.92% |
2017 Q1 | 1.58 Billion JPY | -27.82% |
2016 Q3 | 1.35 Billion JPY | 0.65% |
2016 Q1 | 1.47 Billion JPY | -24.83% |
2016 FY | - JPY | 4.27% |
2016 Q4 | 2.19 Billion JPY | 62.16% |
2016 Q2 | 1.34 Billion JPY | -8.76% |
2015 FY | - JPY | -3.03% |
2015 Q4 | 1.95 Billion JPY | 36.25% |
2015 Q3 | 1.43 Billion JPY | 10.8% |
2015 Q2 | 1.29 Billion JPY | -6.28% |
2015 Q1 | 1.38 Billion JPY | -38.92% |
2014 Q3 | 1.25 Billion JPY | -6.18% |
2014 Q4 | 2.26 Billion JPY | 80.81% |
2014 FY | - JPY | 3.62% |
2014 Q1 | 1.37 Billion JPY | -30.21% |
2014 Q2 | 1.33 Billion JPY | -3.13% |
2013 Q2 | 1.31 Billion JPY | 1.55% |
2013 Q3 | 1.41 Billion JPY | 7.43% |
2013 FY | - JPY | 9.52% |
2013 Q4 | 1.97 Billion JPY | 39.67% |
2013 Q1 | 1.29 Billion JPY | -28.51% |
2012 Q1 | 1.31 Billion JPY | -20.68% |
2012 Q3 | 1.43 Billion JPY | 75.61% |
2012 Q4 | 1.81 Billion JPY | 26.23% |
2012 FY | - JPY | 3.98% |
2012 Q2 | 818.03 Million JPY | -37.7% |
2011 Q1 | 1.16 Billion JPY | -72.36% |
2011 FY | - JPY | -24.11% |
2011 Q3 | 1.43 Billion JPY | 43.12% |
2011 Q2 | 1 Billion JPY | -13.77% |
2011 Q4 | 1.65 Billion JPY | 15.32% |
2010 Q1 | 1.52 Billion JPY | -55.26% |
2010 FY | - JPY | 5.16% |
2010 Q4 | 4.2 Billion JPY | 198.42% |
2010 Q3 | 1.41 Billion JPY | 42.17% |
2010 Q2 | 991.83 Million JPY | -35.03% |
2009 FY | - JPY | 1.19% |
2009 Q3 | 1.46 Billion JPY | 0.99% |
2009 Q2 | 1.44 Billion JPY | 0.46% |
2009 Q1 | 1.43 Billion JPY | -62.86% |
2009 Q4 | 3.41 Billion JPY | 133.68% |
2008 Q3 | 1.04 Billion JPY | -18.5% |
2008 Q4 | 3.87 Billion JPY | 271.44% |
2008 Q2 | 1.28 Billion JPY | 0.0% |
2008 FY | - JPY | -11.65% |
2007 FY | - JPY | 3.43% |
2006 FY | - JPY | 10.0% |
2005 FY | - JPY | 5.11% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
OLBA HEALTHCARE HOLDINGS, Inc. | 2.79 Billion JPY | -353.323% |
Alfresa Holdings Corporation | 51.97 Billion JPY | 75.653% |
Vital KSK Holdings, Inc. | 8.84 Billion JPY | -43.121% |
WIN-Partners Co., Ltd. | 2.91 Billion JPY | -333.972% |
MediPal Holdings Corporation | 65.31 Billion JPY | 80.624% |
Yamashita Health Care Holdings,Inc. | 1.23 Billion JPY | -924.676% |
Suzuken Co., Ltd. | 51.57 Billion JPY | 75.465% |